These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11801287)

  • 1. Characterization of the profile of neurokinin-2 and neurotensin receptor antagonists in the mouse defense test battery.
    Griebel G; Moindrot N; Aliaga C; Simiand J; Soubrié P
    Neurosci Biobehav Rev; 2001 Dec; 25(7-8):619-26. PubMed ID: 11801287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents.
    Griebel G; Perrault G; Soubrié P
    Psychopharmacology (Berl); 2001 Nov; 158(3):241-51. PubMed ID: 11713613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
    Griebel G; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice.
    Griebel G; Perrault G; Sanger DJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):689-94. PubMed ID: 10208374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam.
    Griebel G; Blanchard DC; Jung A; Lee JC; Masuda CK; Blanchard RJ
    Neuropharmacology; 1995 Dec; 34(12):1625-33. PubMed ID: 8788960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A agonists modulate mouse antipredator defensive behavior differently from the 5-HT2A antagonist pirenperone.
    Griebel G; Blanchard DC; Jung A; Masuda CK; Blanchard RJ
    Pharmacol Biochem Behav; 1995; 51(2-3):235-44. PubMed ID: 7667334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries.
    Blanchard RJ; Griebel G; Henrie JA; Blanchard DC
    Neurosci Biobehav Rev; 1997 Nov; 21(6):783-9. PubMed ID: 9415903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin inversely modulates maternal aggression.
    Gammie SC; D'Anna KL; Gerstein H; Stevenson SA
    Neuroscience; 2009 Feb; 158(4):1215-23. PubMed ID: 19118604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity.
    Griebel G; Perrault G; Sanger DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan; 23(1):81-98. PubMed ID: 10368858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of 'antipredator' defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities.
    Griebel G; Blanchard DC; Jung A; Blanchard RJ
    Behav Pharmacol; 1995 Nov; 6(7):732-745. PubMed ID: 11224376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the behaviors in the Mouse Defense Test Battery relate to different emotional states: a factor analytic study.
    Griebel G; Blanchard DC; Blanchard RJ
    Physiol Behav; 1996 Nov; 60(5):1255-60. PubMed ID: 8916179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orphanin FQ, a novel neuropeptide with anti-stress-like activity.
    Griebel G; Perrault G; Sanger DJ
    Brain Res; 1999 Jul; 836(1-2):221-4. PubMed ID: 10415424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic.
    Blanchard DC; Griebel G; Blanchard RJ
    Eur J Pharmacol; 2003 Feb; 463(1-3):97-116. PubMed ID: 12600704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment with SR48692 has different effects on central neurotensin-induced gastric mucosal defense and inhibition of gastric acid secretion in rats.
    Karinch AM; Schmidt GL; Kauffman GL
    Brain Res; 1998 Nov; 810(1-2):123-9. PubMed ID: 9813278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.
    Gully D; Lespy L; Canton M; Rostène W; Kitabgi P; Le Fur G; Maffrand JP
    Life Sci; 1996; 58(8):665-74. PubMed ID: 8594316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
    Griebel G; Perrault G; Sanger DJ
    Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.
    Griebel G; Stemmelin J; Scatton B
    Biol Psychiatry; 2005 Feb; 57(3):261-7. PubMed ID: 15691527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells.
    Oury-Donat F; Thurneyssen O; Gonalons N; Forgez P; Gully D; Le Fur G; Soubrie P
    Br J Pharmacol; 1995 Sep; 116(2):1899-905. PubMed ID: 8528577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.